An emerging treatment option for glaucoma: Rho kinase inhibitors
Sean K Wang,1 Robert T Chang21Stanford University, Stanford, CA, USA; 2Stanford University School of Medicine, Stanford, CA, USAAbstract: Rho kinase (ROCK) inhibitors are a novel potential class of glaucoma therapeutics with multiple compounds currently in phase II and III US Food and Drug Administ...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/6ad1cf805a8448588824577ee1627ab6 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|